Back to Jeremy Grantham
Jeremy Grantham → JNJ via Grantham, Mayo, Van Otterloo & Co. LLC
Jeremy Grantham JNJ Position History
Johnson & Johnson • Healthcare
Quarters held
18
Latest value
$1.8B
Q2 2026
Peak value
$1.8B
First seen
Q1 2023
Quarter-by-quarter history
Every disclosed snapshot
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q2 2026 | $1.8B | 7.11M | — | — |
| Q2 2026 | $786K | 9.5K | — | — |
| Q1 2026 | $1.8B | 7.28M | — | — |
| Q1 2026 | $349K | 4.4K | — | — |
| Q4 2025 | $1.5B | 7.09M | — | — |
| Q3 2025 | $1.3B | 6.82M | — | — |
| Q2 2025 | $1B | 6.55M | — | — |
| Q1 2025 | $1.1B | 6.81M | — | — |
| Q4 2024 | $919.8M | 6.36M | — | — |
| Q3 2024 | $1B | 6.29M | — | — |
| Q2 2024 | $880.5M | 6.02M | — | — |
| Q1 2024 | $763.7M | 4.83M | — | — |
| Q4 2023 | $624.8M | 3.99M | — | — |
| Q3 2023 | $583.3M | 3.74M | — | — |
| Q2 2023 | $220K | 6.5K | — | — |
| Q2 2023 | $556.6M | 3.36M | — | — |
| Q1 2023 | $473K | 12.2K | — | — |
| Q1 2023 | $465M | 3.00M | — | — |